JRCT ID: jRCT2052220073
Registered date:10/08/2022
A multicenter, pivotal study to demonstrate non-inferiority of Cyt-006 compared to Seprafilm in patients with primary rectal cancer and temporal colostomy underwent laparoscopic surgery
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | primary rectal cancer |
Date of first enrollment | 10/08/2022 |
Target sample size | 158 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Application of the anti-adhesion barrier |
Outcome(s)
Primary Outcome | presence/absence of adhesion |
---|---|
Secondary Outcome | Efficacy: Severity score of adhesion Range score of adhesion Presence/absence of ileus Success rate of pasting Safety: Adverse event, device failure or malfunction hematologic tests, blood biochemical tests vital signs |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | |
Include criteria | 1) Patients with initial and primary rectal cancer. 2) Patients with cStage 0 to cStage III. 3) Patients who are scheduled to undergo laparoscopic rectal resection and temporal colostomy. 4) Patients who are scheduled to undergo the closure of artificial anus at 8 to 48 weeks after initial surgery. |
Exclude criteria | Pre-operation: 1) Patients who are scheduled to undergo open abdominal surgery. 2) Patients who had a history of intraperitoneal surgery except for appendicitis, Caesarean section, or laparoscopic cholecystectomy. 3) Patients who are scheduled to remove specimens from the site other than the midline incision (except in the case of robotic surgery). 4) Patients whose performance Status >=3. 5) Patients with 35 or higher of BMI. During Operation: 1) Patients who need to undergo open abdominal surgery during laparoscopic procedure. 2) Patients who did not have a temporary colostomy. 3) Patients whose specimen was removed from a site other than the midline wound (except in the case of robotic surgery). 4) Patients who underwent colostomy at the umbilical site |
Related Information
Primary Sponsor | Horii Yoshihiro |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Yoshihiro Horii |
Address | 1-1-1 Otemachi, Chiyoda-ku, Tokyo Tokyo Japan 100-0004 |
Telephone | +81-3-6860-5712 |
cyt-006-01@cytori-jp.com | |
Affiliation | Cytori Therapeutics K.K. |
Scientific contact | |
Name | Yoshihiro Horii |
Address | 1-1-1 Otemachi, Chiyoda-ku, Tokyo Tokyo Japan 100-0004 |
Telephone | +81-3-6860-5712 |
cyt-006-01@cytori-jp.com | |
Affiliation | Cytori Therapeutics K.K. |